Developing new tests and screening methods for Alzheimer's disease treatments
Assay Development and High Throughput Screening (ADHTS) Core
['FUNDING_OTHER'] · INDIANA UNIVERSITY INDIANAPOLIS · NIH-10950443
This study is looking for new ways to find treatments for Alzheimer's disease that go beyond the usual targets, with the hope of discovering better drugs that could help improve your condition or slow down the disease.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | INDIANA UNIVERSITY INDIANAPOLIS (nih funded) |
| Locations | 1 site (INDIANAPOLIS, UNITED STATES) |
| Trial ID | NIH-10950443 on ClinicalTrials.gov |
What this research studies
This research focuses on creating advanced testing methods and high-throughput screening processes to identify potential new therapies for Alzheimer's disease. By integrating sophisticated biological insights and drug discovery techniques, the project aims to validate new targets for treatment beyond the traditional focus on amyloid beta. Patients may benefit from the development of innovative drugs that could improve their condition or slow disease progression. The research also includes developing biomarkers to guide early clinical trials, which could lead to safer and more effective treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk of developing it.
Not a fit: Patients with other forms of dementia unrelated to Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new therapies that significantly improve the treatment of Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in developing new therapeutic approaches for Alzheimer's disease, indicating that this work builds on established methods.
Where this research is happening
INDIANAPOLIS, UNITED STATES
- INDIANA UNIVERSITY INDIANAPOLIS — INDIANAPOLIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DAGE, JEFFREY — INDIANA UNIVERSITY INDIANAPOLIS
- Study coordinator: DAGE, JEFFREY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease, Alzheimer's disease therapy